Genotropin
Werner's Syndrome
National Center for Research Resources (NCRR)protein_peptideN/ADormant
D
30/ 100
Provisional rating · Methodology v0.2
Rating breakdown
- Clinical Evidence
- 15/ 100
- Competitive Position
- 95/ 100
Competitive context
1 Active assets in the Werner's Syndrome cohort.
| Asset / Sponsor | Phase | Rating |
|---|---|---|
Progerinin PRG Science & Technology Co., Ltd. | Phase 2 | B |
Same molecule, other indications
Genotropin is also rated in:
Are you the sponsor?
Submit your data room for a Verified Rating. The public-data rating remains visible alongside.
Contact →